Literature DB >> 27039688

Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy.

Mingjun Xuan1,2, Jingxin Shao1,3, Luru Dai3, Junbai Li2, Qiang He1.   

Abstract

Macrophage cell membrane (MPCM)-camouflaged gold nanoshells (AuNS) that can serve as a new generation of photothermal conversion agents for in vivo photothermal cancer therapy are presented. They are constructed by the fusion of biocompatible AuNSs and MPCM vesicles. The resulting MPCM-coated AuNSs exhibited good colloidal stability and kept the original near-infrared (NIR) adsorption of AuNSs. Because AuNS carried high-density coverage of MPCMs, the totally functional portions of macrophage cells membrane were grafted onto the surface of AuNSs. This surface functionalization provided active targeting ability by recognizing tumor endothelium and thus improved tumoritropic accumulation compared to the red blood cell membrane-coating approach. These biomimetic nanoparticles significantly enhance in vivo blood circulation time and local accumulation at the tumor when administered systematically. Upon NIR laser irradiation, local heat generated by the MPCM-coated AuNS achieves high efficiency to suppress tumor growth and selectively ablate cancerous cells within the illuminated zone. Therefore, MPCM-coated AuNSs remained the natural properties of their source cells, which may improve the efficacy of photothermal therapy modulated by AuNSs and other noble-metal nanoparticles.

Entities:  

Keywords:  Au nanoshell; biostealth coating; long circulation; macrophage cell membrane; photothermal therapy

Mesh:

Substances:

Year:  2016        PMID: 27039688     DOI: 10.1021/acsami.6b00853

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  59 in total

Review 1.  Progress on Modulating Tumor-Associated Macrophages with Biomaterials.

Authors:  Meilyn Sylvestre; Courtney A Crane; Suzie H Pun
Journal:  Adv Mater       Date:  2019-09-27       Impact factor: 30.849

2.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

Review 3.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

4.  Advances in targeted nanotherapeutics: From bioconjugation to biomimicry.

Authors:  Danielle M Valcourt; Jenna Harris; Rachel S Riley; Megan Dang; Jianxin Wang; Emily S Day
Journal:  Nano Res       Date:  2018-05-17       Impact factor: 8.897

Review 5.  Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles.

Authors:  Ashley V Kroll; Ronnie H Fang; Liangfang Zhang
Journal:  Bioconjug Chem       Date:  2016-11-16       Impact factor: 4.774

Review 6.  Cell membrane-derived nanomaterials for biomedical applications.

Authors:  Ronnie H Fang; Yao Jiang; Jean C Fang; Liangfang Zhang
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

Review 7.  Inflammation and Cancer: In Medio Stat Nano.

Authors:  Roberto Molinaro; Claudia Corbo; Megan Livingston; Michael Evangelopoulos; Alessandro Parodi; Christian Boada; Marco Agostini; Ennio Tasciotti
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

Review 8.  Nanomedicines for dysfunctional macrophage-associated diseases.

Authors:  Hongliang He; Shobha Ghosh; Hu Yang
Journal:  J Control Release       Date:  2017-01-03       Impact factor: 9.776

Review 9.  Cell Membrane Coating Nanotechnology.

Authors:  Ronnie H Fang; Ashley V Kroll; Weiwei Gao; Liangfang Zhang
Journal:  Adv Mater       Date:  2018-03-27       Impact factor: 30.849

Review 10.  Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer.

Authors:  Yijing Liu; Pravin Bhattarai; Zhifei Dai; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2019-04-01       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.